Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor, and Pensions Committee on Wednesday. He faced questions on vaccines, HHS cuts, and other issues.
UnitedHealth Group announced that Andrew Witty will step down as CEO due to ‘personal reasons.’ He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017.
Position your firm for long-term growth with better financial visibility and control. Learn how to track performance, manage spending, and plan strategically—download the full e-book now.
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries.
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency, and personalized communication.
Employers should review their contracts, conduct claims analyses, and more to meet their fiduciary responsibility, according to one expert.
Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report.
Here’s What The Best Ones Are Doing Differently.
The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA, and more.
The Department of Justice has filed a complaint against Aetna, Elevance Health, Humana, eHealth, GoHealth, and SelectQuote, alleging that the insurers paid illegal kickbacks to brokers to boost enrollment in their Medicare Advantage plans.
Compounding pharmacies must stop making their versions of the metabolic medicines or face FDA enforcement action.
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding assets to cope with the current macroeconomic environment.
This tweak to your financial management seems like a no-brainer.
Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place.
Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies.
The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, regulators, and platforms — must collaborate to sustain that trust.
Robert F. Kennedy Jr.’s rise to become secretary of the Department of Health and Human Services has some concerned that anti-vaccine policies are coming. If the nation’s top public health agency pulls support of vaccination, other healthcare stakeholders will need to step up to fill the vaccine messaging void.
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could wosen care quality and force hospitals to make tough financial decisions — from cutting services to delaying tech upgrades.